期刊
ARCHIVES OF NEUROLOGY
卷 62, 期 5, 页码 795-800出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archneur.62.5.795
关键词
-
资金
- NINDS NIH HHS [NS23132, N01-NS-0-2397] Funding Source: Medline
Background: We have previously shown that the inducible kinin B-1 receptor is expressed on T lymphocytes during relapses and progression in multiple sclerosis. Objective: To evaluate the correlation between the expression of B-1 receptor on peripheral blood mononuclear cells derived from patients who have multiple sclerosis with serial, clinical magnetic resonance imaging and immunological study-derived measures. Design: Using frozen samples obtained from a high-frequency magnetic resonance imaging-immunological study, we analyzed B-1 receptor messenger RNA (mRNA) expression in peripheral blood-derived mononuclear cells serially collected from 6 patients with multiple sclerosis and 8 healthy control subjects by semiquantitative radioactive duplex reverse transcriptase-polymerase chain reaction amplification. Time-course kinin B-1-actin mRNA ratios were subsequently compared with corresponding clinical magnetic resonance imaging and immune parameters. Results: The time-course kinin B-1-actin mRNA ratio correlated positively with the Expanded Disability Status Scale index (P<.001), occurrence of clinical relapse (P=.02), volume of lesion on T2-weighted images (P<.003) and interleukin 2 receptor and major histocompatibility complex class II expression on CD4(+) lymphocytes, but not with gadolinium-enhancing lesions. The time-course kinin B-1-actin mRNA ratios were 5 to 25 times lower in samples derived from healthy controls. Conclusion: The correlation of kinin B-1 receptor mRNA levels with dynamic clinical and magnetic resonance imaging measures suggests that expression of this receptor can serve as an index of disease activity in multiple sclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据